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ABSTRACT The glial cells missing (gcm) gene in Drosoph-
ila encodes a transcription factor that determines the choice
between glial and neuronal fates. We report here the isolation
of two mammalian gcm homologs, Gcm1 and Gcm2, and the
characterization of their expression patterns during embry-
onic development. Although Gcm2 is expressed in neural
tissues at a low level, the major sites of expression for both of
the mammalian genes are nonneural, suggesting that the
functions of the mammalian homologs have diverged and
diversified. However, when expressed ectopically, Gcm1 can
substitute functionally for Drosophila gcm by transforming
presumptive neurons into glia. Thus, certain biochemical
properties, although not the specificity of the tissue in which
the gene is expressed, have been conserved through the
evolution of the Gcm gene family.
The Drosophila gene glial cells missing (gcm) controls the
binary fate decision between neuronal and glial lineages (1–3).
Loss-of-function mutations in gcm result in conversion of
presumptive glial cells into neurons, whereas ectopic expres-
sion of gcm generates additional glial cells at the expense of
neurons. Based on its nuclear localization and sequence-
specific DNA-binding activity, GCM was proposed to be a
transcriptional activator for glial-specific genes. Consistent
with this, multiple copies of the proposed GCM-binding
elements are found in the putative upstream regulatory region
of a glial-specific gene, reverse polarity (repo) (4). GCM was
also shown to be able to activate a reporter gene in a
GCM-binding-site-dependent manner in transiently trans-
fected cells (5).
Many vertebrate homologs of Drosophila transcription fac-
tors involved in neurogenesis have been isolated and shown to
be expressed specifically in neural tissues (6, 7). This is
particularly well established for proteins belonging to the basic
helix–loop–helix family (8). However, no mammalian genes
thus far discovered fulfill the role of a glial fate-determination
gene. Thus, it was of significant interest to examine the possible
role of mammalian homologs of the gcm gene in the neuron–
glia fate decision. Recently, two mammalian gcm homologs
have been identified (4, 9). Not surprisingly, the DNA-binding
domain, now called the gcm motif, is conserved, whereas the
rest, likely responsible for interaction with other proteins, is
not. Although one report made a preliminary claim that one
of the homologs is expressed in embryonic neural tissues (4),
no detailed study of the expression pattern has been presented
thus far.
We describe here the isolation of the two rodent Gcm genes
and the characterization of their expression patterns by in situ
hybridization and reverse transcription–PCR (RT-PCR). The
results indicate that the major sites of expression in embryos
are not neural for either of the rodent genes, although their
expression is highly specific to certain nonneural tissues. Thus,
their function is, for the most part, not conserved from that of
Drosophila gcm. Interestingly, one of the homologs, Gcm1 but
not Gcm2, was able to generate extra glial cells when expressed
in Drosophila and could partially rescue the loss-of-function
phenotype, indicating that Gcm1 shares conserved regulatory
capabilities with gcm.
MATERIALS AND METHODS
Isolation of Rodent Homologs of gcm. A pair of degenerate
oligonucleotide primers (59-CGGATCCAGACCT/CGCCATT/
CTGT/CGACAAG-39 corresponding to the sequence coding
for amino acids RPAICDK and 59-CGGAATTCTTCT/
GGGTT/CTT/GGGA/GTGATCA/GTG-39 corresponding to the
complementary sequence coding for amino acids HDHPR/
KPE) was used to screen by PCR amplification a rat placental
cDNA library that was built in the plasmid vector pcDNA3
(Invitrogen) and divided into 50 groups. A positive pool was
transformed into Escherichia coli, and the resulting transfor-
mants were screened with a 32P-labeled probe derived from the
PCR product. Several positive clones were sequenced and
identified as rat Gcm1 (rGcm1). The 39 end of rGcm1 was
determined by 39 rapid amplification of cDNA ends by using
a cDNA preparation from embryonic day 14.5 (E14.5) rat
placental tissue primed with an anchored oligo(dT) primer
(59-CCAGTGAGCAGAGTGACGAGGACTCGAGCTCA-
AGCTTTTTTTTTTTTTT-39) as the template. The primers
used for the first 30 PCR cycles were 59-CCTGTGGATT-
TCAGCAGC-39 and 59-CCAGTGAGCAGAGTGACG-39.
Primers for the second 30 cycles were 59-TCGCTTACG-
GCTCTCATC-39 and 59-GAGGACTCGAGCTCAAGC-39.
The same 32P-labeled probe was used to screen a 129SvEv
mouse genomic DNA library built in the phage vector l DASH
II (Stratagene). The positive clones were divided into two
groups based on the strength of hybridization. Partial sequence
analyses confirmed that the strongly hybridizing group con-
tained Gcm1 clones, whereas the other was composed of a
distinct yet homologous gene called Gcm2. Several overlap-
ping genomic clones were sequenced, and from over 5 kb of
composite sequence, a partial cDNA sequence for mouse
Gcm2 (mGcm2) was proposed (see Results).
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To isolate a full-length mGcm2 cDNA, two successive
30-cycle rounds of PCR amplification were run with a cDNA
preparation from E13.5 mouse pharyngeal tissue as the tem-
plate. The oligonucleotide primers used were based on the
genomic DNA sequence and the subsequently published
mGcm2 cDNA sequence (GenBank accession no. D88611; ref.
4). For the first 30-cycle round, primers were 59-CTCTT-
TCAGGGCCCTGACTAG-39 and 59-CATAAATGCAC-
CCTTGGCGTG-39; for the second 30 cycles, primers were
59-GATCGAATTCAATGCCAGCAGACAGCACG-39 and
59-GATCGGATCCCTGGATTTCTCTTAAAAGTCC-39.
The resulting full-length product was ligated to pCR2.1 with a
TA Cloning kit (Invitrogen; now called pG2–24). To generate
a mGcm2 construct containing the 59 UTR (untranslated
region), a pair of primers (59-GATCGAGCTCCTTTGTGT-
GTATATCTGCCTC-39 and 59-TGTCCCACGTGAGTT-
TCATCC-39) was used to PCR amplify from genomic DNA a
300-bp product containing 220 bases of 59 UTR and parts of
the first exon. This product was digested with SacI and PmlI
and inserted into pG2–24 (p5G2–24). To generate a construct
with a MYC-epitope tag, a three-way ligation was performed
with the following DNA fragments: (i) p5G2–24 digested with
BsgI and XhoI, (ii) a PCR product amplified from p5G2–24
with primers 59-TCGAGTCCATATTCCACCCTG-39 and 59-
GATCGGATCCAAAGTCCTCATTGTCAAAGC-39 di-
gested with BsgI and BamHI, and (iii) a PCR product amplified
from pCS21MT (10) with primers 59-TGCAGGATCCCATC-
GATTTAAAGC-39 and 59-GCATCTCGAGTTAGGTGAG-
GTCGCCCAAGCTCTC-39 digested with BamHI and XhoI.
The resulting construct has the 59 UTR, mGcm2 ORF, and five
MYC-epitope tags in tandem (p5G2-myc).
In Situ Hybridization. In situ hybridization on frozen sec-
tions and whole-mount in situ hybridization were performed as
described with minor modifications (11). Detailed protocols
are available on request. For Gcm1, the antisense probe was
derived from the longest rGcm1 cDNA clone (see above). For
the mGcm2 probe template, a pair of primers (59-
ATGCGAATTCGCAAGAAGCACTCAGGAC-39 and 59-
CTAGTCTAGAGTCCTCATTGTCAAAGCTAAAGGGC-
39) was used to PCR amplify a 927-base fragment correspond-
ing to the 39 end exon of mGcm2 from mouse genomic DNA.
After EcoRI and XbaI digestion, the fragment was inserted
into the pBluescript KS (1) plasmid. The template for the
parathyroid hormone (PTH) gene probe (a kind gift from B.
Lanske) has been described (12).
RT-PCR. Total RNA preparations were extracted from '50
mg of B6D2F2 mouse embryonic tissues with RNAzol B
(Leedo Medical Laboratories, Houston, TX) following the
manufacturer’s protocol. Oligo(dT)-primed reverse transcrip-
tion was performed on the total RNA preparations with the
SuperScript Preamplification System (GIBCO/BRL) follow-
ing the manufacturer’s protocol. First-strand cDNAs thus
generated served as templates for PCR amplification. For the
amplification of actin cDNA, a pair of primers (59-
CACACITTCTACAATGAGCTGCGTGT-39 and 59-GGT-
GAGGATCTTCATGAGGTAGTC-39) was used for a single
30-cycle round of PCR. For mGcm1 and mGcm2, two succes-
sive 30-cycle rounds of PCR were run. For mGcm1, the
first-round primers were 59-GCACGAATTCAATGGAACT-
GGACGACTTTG-39 and 59-TAGCTGCTCAGATCCA-
CAGA-39, and the second-round primers were 59-CTGCAAT-
GGACCCCTGAAACTAATTCCC-39 and 59-CTGCT-
TCTAGCTTGGTCTCCGGCCTGGG-39. For mGcm2, the
first-round primers were 59-ATGCGAATTCGCAGCCAG-
GAGAAGAAGG-39 and 59-CTAGTCTAGACAGGGCAG-
CTCTAGGTTG-39, and the second-round primers were 59-
TGGGCCATGCGCAACACCAAC-39 and 59-GG-
GAAGCTGCTATCAGCAGTC-39.
Drosophila Stocks. The gcm null allele gcmDP1 and UAS-gcm
(upstream activating sequence-gcm) reporter lines have been
described (2). The sca-Gal4 line was obtained from C. Kla¨mbt
(13).
Generation and Analysis of UAS-Gcm Transgenic Reporter
Lines in Drosophila. A 1.4-kb rGcm1 cDNA was subcloned as
an EcoRI fragment into the EcoRI site of pUAST, a UAS
reporter P-element vector (14). The mGcm2 cDNA (from
p5G2–24) and the mGcm2-myc cDNA (from p5G2-myc) were
first subcloned as SacI–XbaI fragments into pUC18, then
reisolated as EcoRI–XbaI fragments, and subcloned into the
EcoRI and XbaI sites of pUAST. Transgenic lines were
generated by P-element-mediated transformation by standard
procedures. Panneural expression was achieved by crossing
these lines with sca-Gal4. Expression of UAS-gcm and UAS-
rGcm1 in a gcm null background was achieved by first recom-
bining second-chromosome inserts with a gcmDP1 second chro-
mosome to create the following stocks: w; P[w1 UAS-gcm]2
gcmDP1/CyO and w; P[w1 UAS-rGcm1]2B gcmDP1/CyO. These
lines were crossed against w; gcmDP1 sca-Gal4/CyO.
Immunohistochemical Detection of REPO Protein in Dro-
sophila Embryos. Recombinant REPO-fusion protein was
produced in E. coli with the QIAexpress system (Qiagen,
Chatsworth, CA). A 1.4-kb BamHI-HindIII fragment from the
repo cDNA pcrepo-2.6 (15) encoding for amino acids 219–612
was cloned into the pQE-30 expression vector. The resulting
fusion protein has a 22-aa N-terminal addition that contains six
histidine residues, allowing for a one-step purification by
immobilized Ni21 chelate-affinity chromatography. Mice were
injected with 50 mg of protein emulsified in RIBI adjuvant
(Immunochem Research, Hamilton, MO) and were boosted at
2-week intervals. Horseradish peroxidase immunohistochem-
istry and embryo dissections were carried out as described
(16). Anti-REPO antiserum was used at 1:1000 dilution,
followed by horseradish-peroxidase-conjugated goat anti-
mouse secondary antibody (Jackson ImmunoResearch) at
1:300 dilution. The diaminobenzidine reaction was enhanced
by the addition of 0.064% NiCl to give a black color. mGCM2-
MYC protein was detected with anti-c-MYC mAb 1-9E10.2
(17) at 1:5 dilution followed by horseradish-peroxidase-
conjugated goat anti-mouse secondary antibody.
RESULTS
Cloning of Rat Gcm1. A database search with the sequence
of Drosophila gcm gene led to the identification of a human
expressed sequence tag clone (GenBank accession no.
R62635) exhibiting a region of significant homology from a
placental cDNA library. A pair of degenerate primers derived
from amino acids conserved between the human and Drosoph-
ila genes was used to screen a subdivided rat E14.5 placental
cDNA library by PCR amplification of the corresponding
portion of the rat homolog. The PCR product was used
subsequently to screen bacterial transformants of a positive
pool leading to the isolation of rGcm1 cDNA clones. The
longest clone had a 1.4-kb insert comprising 160 bases of 59
untranslated region and an ORF encoding a predicted peptide
of 423 amino acids. The C-terminal sequence was obtained
from a 39 rapid amplification of cDNA ends by using rat
placenta as the source of cDNA. The complete ORF of rGcm1
encodes a 436-aa protein (Fig. 1A). As expected, the region
corresponding to the DNA-binding domain, the gcm motif,
shows a high degree of conservation with Drosophila GCM
(60% identity at the amino acid level). Additionally, rGcm1 is
homologous to mGcm1 (mGcm1: GenBank accession no.
U59876; mGCMa: GenBank accession no. D88612; refs. 4 and
9) throughout the ORF (87% identity at the amino acid level;
Fig. 1A).
Strain-Specific Sequence Variations Among Murine Gcm2
Genes. Screening several cDNA libraries did not lead to the
isolation of additional gcm homologs. However, the results
from screening a mouse genomic DNA library indicated that
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at least one more member of the Gcm family existed. Partial
sequencing of the genomic clones that hybridized to the
aforementioned Gcm1 probe led to the identification of
mGcm2. We obtained the sequence of over 5 kb of genomic
DNA from overlapping phage clones, and from this composite
sequence, generated a potential partial cDNA sequence for
mGcm2 (Fig. 1B; 129SvEv). A comparison with the subse-
quently published murine cDNA sequence (mGCMb: Gen-
Bank accession no. D88611) confirmed that our proposed
sequence accounts for the C-terminal 474 amino acids of
mGCM2 (4).
We independently isolated a full-length mGcm2 cDNA from
the C57BL/6 strain. Interestingly, the sequence of this cDNA
clone showed variations from the sequence of the genomic
DNA that originated from the 129SvEv strain (Fig. 1B).
Specifically, 14 nucleotide differences, of which 7 lead to
changes in amino acid residues, were discovered. All of these
missense alterations are found outside the gcm motif. To
determine whether these differences reflect strain-specific
variations, RNA editing, or the existence of multiple Gcm2
alleles, we compared genomic mGcm2 sequences of the two
mouse strains (129SvEv and C57BL/6) by using PCR ampli-
fication of genomic DNA with both intron- and exon-derived
oligonucleotide primers. The data indicated that a single and
distinct Gcm2 allele is present for each strain. We also noted
that the sequence of the published Gcm2 cDNA isolated from
BALB/c strain (GenBank accession no. D88611; ref. 4) is at
variance with those of the two mGcm2 alleles we isolated (Fig.
1B). A genomic DNA sequence analysis of the BALB/c Gcm2
gene indicated that its sequence is in full agreement with that
of 129SvEv. Furthermore, although all four differences (of
which three lead to amino acid changes) between these
genomic DNAs and the published BALB/c cDNA are A to G
transitions, we found no evidence of RNA editing, as Gcm2
cDNAs isolated from both neural and pharyngeal tissues of
BALB/c mice had sequences identical to the BALB/c genomic
DNA sequence (data not shown). Although the simplest
explanation is that these A to G transitions represent sequenc-
ing errors, we cannot exclude the possibility that the published
BALB/c mGcm2 cDNA is derived from an mRNA that
underwent RNA-editing in the specific tissue (male-adult
brain) from which the mRNA was obtained.
Expression of Gcm1 and Gcm2. We used RNA in situ
hybridization to examine the expression patterns of Gcm1 and
Gcm2 in developing murine embryos. Gcm1 was detected in a
subset of cells in the placenta (Fig. 2 A and B). The location
of the positive cells within the placenta suggests that they are
labyrinthine trophoblasts. No other tissue examined was pos-
itive for Gcm1 transcripts by in situ hybridization. The expres-
sion of Gcm2 also appeared to be highly restricted. Only
parathyroid tissue was positive for Gcm2 (Fig. 2C). A com-
parison to PTH gene expression (Fig. 2D) on adjacent sections
indicated that the cells expressing Gcm2 are PTH-secreting
cells. The expression of Gcm2 in parathyroid tissue is consis-
tent with the isolation of a human Gcm2 cDNA from an adult
parathyroid adenoma (GenBank accession no. AA782779; Fig.
1C). A developmental time course analysis of Gcm2 expression
showed that it is expressed as early as E10, preceding the
expression of PTH (data not shown).
FIG. 1. (A) Comparison of rGCM1 and mGCM1. The deduced amino acid sequence of rGCM1 is aligned with that of mGCM1 in the database
(GenBank accession no. U59876). Conserved residues are boxed. The extent of the gcm motif is indicated by arrowheads. (B) Comparison of the
strain-specific mGCM2 sequences. The sequence for 129SvEv GCM2 is based on the partial cDNA sequence proposed from the genomic DNA
sequence. For C57BL/6, the sequence is based on a full-length cDNA clone. D88611 (GenBank accession no. D88611) represents the published
BALB/c GCMb sequence. Missense alterations found in C57BL/6 and BALB/c sequences with respect to residues in 129SvEv are boxed. (C)
Comparison of mGCM2 and human GCM2 (hGCM2; GenBank accession no. AA782779). Conserved residues are boxed.
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In addition to the placenta, Gcm1 has been reported to be
expressed in the embryo proper during early stages of devel-
opment (9). To examine the expression of Gcm1 in nonpla-
cental embryonic tissues, we used RT-PCR to amplify Gcm1
transcripts. The Gcm1 mRNA was detected at E9.5 in both the
head and body but was not detected at E11.5 (Fig. 3).
Additionally, the Gcm1 message could be amplified from a
E16.5 kidney cDNA preparation. With the exception of the
placenta, the detection of the Gcm1 message by RT-PCR
required extended cycles of amplification. Taken together with
the fact that no transcripts were detected by in situ hybridiza-
tion to embryonic tissue even at stages where signals were
detectable by RT-PCR, the data suggest that the primary if not
the exclusive site of embryonic Gcm1 expression is the pla-
centa.
A similar RT-PCR analysis was performed for Gcm2. The
message was detected in both head and body at E9.5 but was
restricted to the head region by E11.5 (Fig. 3). At E16.5, we
detected the message from the placenta and the cortex of the
embryo. The detection of the Gcm2 message in embryonic
neural tissues is consistent with the reported isolation of Gcm2
cDNA from an adult brain cDNA library (4). Nevertheless, the
detection of Gcm2 in neural tissue also required extended
cycles of amplification, suggesting that the levels of expression
are extremely low in all tissues except the parathyroid gland.
Expression of rGcm1 in Drosophila. It has been shown that
the gcm gene in Drosophila controls the choice between glial
and neuronal fates in most glial lineages (1–3). In Drosophila,
the GCM protein is expressed transiently in all embryonic glia
except the mesectodermally derived midline glia. GCM-
positive glia are also characterized by the expression of the
homeodomain protein, REPO (15, 18, 19). Transient expres-
sion of GCM in developing glial cells is followed by maintained
expression of REPO (Fig. 4A). In gcm-homozygous null
mutant embryos, nearly all presumptive glia fail to differen-
tiate into glia, and virtually all REPO expression is eliminated
(Fig. 4B). This phenotype is associated with an increase in
markers normally expressed in differentiated neuronal cells,
suggesting that glial-cell precursors have been transformed
into neurons (1, 2). Conversely, when GCM is expressed
ectopically in neural precursors, there is a dramatic increase in
the number of REPO-expressing cells (1, 2) (Fig. 4C). These
REPO-positive cells exhibit glial morphologies at the expense
of neuronal markers and morphologies, suggesting that pre-
sumptive neurons have been transformed into glia (1).
FIG. 2. (A and B) Expression of rGcm1 in rat E14.5 placenta. The section was hybridized with an antisense cDNA probe for rGcm1. A positive
region in A is shown in enlarged form in B. (C) Sagittal section of the pharyngeal region of an E16.5 mouse showing mGcm2 expression in the
parathyroid tissue. (D) The adjacent section was positive for parathyroid hormone gene transcript. (Scale bars: 500 mm for A and 100 mm for C.)
FIG. 3. RT-PCR analyses of the expression of Gcm genes. Agarose-
gel electrophoresis of the PCR products is shown. Oligo(dT) primed
cDNA derived from mouse tissues were amplified with gene-specific
primers. Actin cDNA was amplified as the control product. Oligonu-
cleotide primers that span exon–intron junctions were used so as to be
able to distinguish spliced messages from genomic DNA contamina-
tion. In addition, for each of the PCRs, a control reaction that used a
cDNA preparation without reverse transcription was performed and
shown to generate no product (data not shown).
FIG. 4. Panneural expression of rGCM1 promotes glial-cell differ-
entiation in Drosophila. Photomicrographs of the central nervous
system (CNS) in stage 16 embryos showing four adjacent segmental
neuromeres as stained with anti-REPO antisera. (A) Wild-type em-
bryo. Anti-REPO stains the nuclei of all glial cells except midline glia.
(B) gcmDP1 loss-of-function mutant embryo. Virtually no cells express
REPO. (C) Panneural expression of Drosophila GCM. In sca-Gal4/
UAS-gcm; UAS-gcm/1 embryos (expressing two copies of UAS-gcm),
panneural expression of GCM causes nearly all CNS cells to express
REPO. (D) Panneural expression of rGCM1. In UAS-rGcm1/1;
sca-Gal4/UAS-rGcm1 embryos (expressing two copies of UAS-
rGcm1), panneural expression of rGCM1 also causes an increase in
REPO expression in the CNS. Anterior is up. (Scale bar: 10 mm.)
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Drosophila embryos that express rGcm1 and mGcm2 in
neural precursors were generated with the GAL4-UAS system
to test whether vertebrate homologs of gcm are conserved
functionally (14). We constructed fusion genes that place
rGcm1 and mGcm2 cDNAs under the control of a UAS, which
allows them to be activated by the GAL4 transcriptional
activator in specific tissues where Gal4 is expressed. Ectopic
expression in the CNS was achieved by crossing these UAS
reporter lines with a GAL4 effector line (sca-Gal4) that drives
Gal4 expression panneurally (13).
Panneural expression of rGCM1 caused a dramatic increase
in the number of REPO-positive cells (Fig. 4D) similar to the
phenotype obtained with GCM (Fig. 4C). In embryos carrying
two copies of UAS-rGcm1 and one copy of sca-Gal4, '70% of
CNS cells per abdominal segment expressed REPO, compared
with a wild-type level of 23% (compare Fig. 4D with Fig. 4A).
Most of these ectopic REPO-positive cells display the elon-
gated morphology typical of glial cells. This phenotype is not
as penetrant as that obtained by ectopically expressing two
copies of Drosophila GCM panneurally, which causes nearly all
CNS cells to express REPO (Fig. 4C).
We were curious to find out whether the endogenous gcm
locus is required for these transformations. In particular,
rGCM1 might exert its effect on repo expression indirectly via
activation of endogenous gcm. We therefore generated flies
that carry one copy of UAS-rGcm1, together with a loss-of-
function mutation in gcm on the second chromosome. These
were crossed against f lies that carry sca-Gal4 and a gcm
loss-of-function mutation also on the second chromosome. Of
the resulting F1 embryos, one-fourth should express rGCM1
panneurally in a gcm-homozygous null background. In the
absence of endogenous GCM expression, rGCM1 was capable
of inducing REPO expression (Fig. 5B; compare with gcm
loss-of-function in Fig. 4B). Many of these REPO-positive cells
display glial phenotypes, though they lack the patterning
imposed by endogenous GCM expression. These embryos are
almost indistinguishable from embryos in which one copy of
native Drosophila gcm gene is expressed under the control of
sca-Gal4 in a gcm-homozygous null background (Fig. 5A).
Thus, the function of rGCM1 in flies is independent of the
endogenous gcm gene.
We were unable to detect any phenotypes associated with
panneural expression of UAS-mGcm2. The embryos showed
no ectopic REPO expression and developed into normal viable
adults. To confirm that mGcm2 was properly translated, we
engineered an MYC-epitope-tagged version of UAS-mGcm2
and assayed for its expression in embryos with anti-c-MYC
mAb 1-9E10.2 (17). An 81-aa MYC-tag-encoding DNA frag-
ment was cloned in frame with the 39 end of the ORF of the
mGcm2 cDNA, such that the entire mGcm2 ORF must be
translated for the MYC epitope to be detected. Transgenic
flies carrying UAS-mGcm2-myc were generated and were
crossed to the sca-Gal4 activator line. Strong nuclear expres-
sion of MYC-tagged mGCM2 protein was detected in the
nervous system of embryos generated from this cross. This
expression confirms the translation of mGcm2 cDNA, but
these embryos exhibit no neural phenotype (data not shown).
DISCUSSION
Molecular analyses of transcription factors involved in embry-
onic development have shown that homologs not only exist
across the metazoa but are often expressed in analogous tissues
and play comparable roles (7). In fact, searching for mamma-
lian homologs of Drosophila genes has been a fruitful approach
in discovering genes involved in specific developmental pro-
grams (8, 20, 21). Thus far, no mammalian gene has been
shown to fulfill the role of a glial determination factor. Thus,
it was of significant interest to isolate and characterize the
mammalian homologs of Drosophila gcm, a transcription factor
whose activity promotes glial over neuronal fates in multipo-
tential neural precursors (1–3).
We isolated two mammalian genes with extended homology
to gcm, Gcm1 and Gcm2. As in other conserved families of
transcription factors, the homology is limited to the DNA-
binding domain, the gcm motif. While these studies were in
progress, similar sequences were reported by two other labo-
ratories (4, 9). The sequences designated by Hotta et al. as
GCMa and GCMb (4) correspond to our GCM1 and GCM2
sequences, respectively. However, our C57BL/6 Gcm2 cDNA-
derived amino acid sequence differs from that of the BALB/
c-derived Gcmb (GenBank accession no. D88611) sequence at
10 different positions. Our comparison of C57BL/6 and
BALB/c genomic Gcm2 sequences showed that 7 of 10 of these
differences represent strain-specific variations. The remaining
three nucleotide differences that result in amino acid changes
and one silent nucleotide difference likely represent sequenc-
ing errors, although the possibility of tissue-specific RNA
editing cannot be excluded (see Results). The two published
mouse Gcm1/a cDNA sequences (GenBank accession nos.
U59876 and D88612) also differ from each other at four amino
acids, though we have not investigated whether these represent
strain-specific differences. All of the differences among
Gcm1/a as well as the strain-specific differences among
Gcm2/b are outside the gcm motif, suggesting that selection
pressure is lower outside the DNA-binding domain.
Our studies on the expression pattern of the two genes by
RNA in situ hybridization and RT-PCR indicate that the roles
of these genes in mammals have diverged and diversified
compared with their Drosophila homolog. Although Gcm2 is
expressed weakly in embryonic neural tissues, both Gcm1 and
Gcm2 are most highly expressed in specific nonneural tissues.
For example, the expression of Gcm1 is highest in a subset of
placental labyrinthine trophoblasts. Similarly, Gcm2 appears
to be the first described transcription factor that is expressed
specifically in the PTH-secreting cells of the developing para-
thyroid gland. Such specific expression of Gcm2 suggests that
it plays an important role in the development of the parathy-
roid gland and possibly in the transcription of the PTH gene.
Why should the neural expression of Drosophila transcrip-
tion factors such as achaete-scute and atonal be conserved in
vertebrates, whereas the neural expression of gcm is not? Many
terminal differentiation genes specifically expressed in neu-
rons are conserved between Drosophila and mammals, includ-
ing ion channels, synaptic vesicle proteins, adhesion molecules,
FIG. 5. rGCM1 rescues glial differentiation in gcm loss-of-function
mutant embryos. Photomicrographs of the CNS in stage 16 embryos
showing four adjacent segmental neuromeres as stained with anti-
REPO antisera. (A) Panneural expression of Drosophila GCM in a
gcm loss-of-function mutant embryo (UAS-gcm gcmDP1/gcmDP1 sca-
Gal4) promotes REPO expression and glial-cell development. (B)
Panneural expression of rGCM1 in a gcm loss-of-function mutant
embryo (UAS-rGcm1 gcmDP1/gcmDP1 sca-Gal4) also promotes REPO
expression and glial-cell development. Anterior is up. (Scale bar: 10
mm.)
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and neurotransmitter-synthesizing enzymes. Strong evolution-
ary-selection pressure to conserve the mechanisms that regu-
late their expression in neurons would explain why the tissue
specificity of neuronal transcription-factor gene expression is
conserved in parallel with sequences of their DNA-binding
domains. By contrast, none of the terminal differentiation
genes expressed in vertebrate glia, such as myelin proteins or
glial fibrillary acidic protein, appear to have counterparts in
Drosophila. This lack of molecular conservation of terminal
differentiation genes may indicate that Drosophila glia are
functionally much more diverged from mammalian glia than
fly neurons are from mammalian neurons. In that case, there
would be little selection pressure to maintain tissue specificity
of expression for a fly glial determination gene. Rather, the
gcm motif would be conserved as a mechanism to control
tissue-specific gene expression, but would be evolutionarily
coopted by nonglial tissues.
These arguments not withstanding, it should be noted that
the data presented here do not exclude the possibility that
Gcm1 and Gcm2 do have some function in neurogenesis,
because both appear to be expressed in embryonic neural
tissues during early embryonic stages, albeit at levels unde-
tectable by in situ hybridization. Loss of function analyses of
Gcm1 and Gcm2 may be required to establish the significance
of their low-level expression in neural tissues. It is also possible
that there are additional members of the mammalian Gcm
family, some of which may be more closely related in function
to Drosophila gcm than Gcm1 or Gcm2.
Ectopic expression of homologous vertebrate transcription
factors in flies can lead to phenotypes similar to those observed
in gain-of-function mutations or can result in rescue of loss-
of-function phenotypes (22–25). Such results suggest a con-
servation of functional properties at the biochemical level
among the homologs in question. The fact that rGcm1 can
substitute partially for gcm when expressed in Drosophila
suggests that key properties of rGCM1 as a transcription factor
are conserved with respect to those of GCM. Thus, we can
safely conclude that rGCM1 is a transcriptional activator with
a DNA-binding specificity similar to that of GCM. In fact,
recently it has been shown that mGCM1 and Drosophila GCM
bind to the same DNA elements (26). Surprisingly, mGcm2,
whose degree of homology to gcm in the DNA-binding domain
is similar to that of rGcm1, failed to substitute for gcm. Several
possibilities may explain this result: (i) GCM2 may have a
binding site distinct from Drosophila GCM and GCM1; (ii)
GCM2 may not be a transcriptional activator but a transcrip-
tional repressor; or (iii) Drosophila GCM and GCM1 may use
a common cofactor that GCM2 does not. Further analyses,
including the identification of GCM2 binding sites and domain
swapping between GCM1 and GCM2, should help to distin-
guish amongst these possibilities.
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